TrialInternational journal of clinical oncology2011

Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy.

Yoshihiro Yakushijin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.